|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,120.00 GBX | -0.68% |
|
+5.50% | +2.39% |
| 01-13 | S&P 500, Dow Clinch New Peaks as Traders Shrug Off Fed Independence Concerns | MT |
| 01-12 | Equities Rise Intraday Amid Probe Into Fed Chair Powell | MT |
| Capitalization | 295B 253B 235B 219B 409B 26,585B 439B 2,706B 1,064B 12,718B 1,106B 1,083B 46,633B | P/E ratio 2025 * |
28.7x | P/E ratio 2026 * | 25.1x |
|---|---|---|---|---|---|
| Enterprise value | 316B 271B 252B 235B 439B 28,515B 471B 2,902B 1,141B 13,642B 1,187B 1,162B 50,019B | EV / Sales 2025 * |
5.4x | EV / Sales 2026 * | 4.98x |
| Free-Float |
96.62% | Yield 2025 * |
1.7% | Yield 2026 * | 1.79% |
Last Transcript: AstraZeneca PLC
| 1 day | -0.68% | ||
| 1 week | +5.50% | ||
| Current month | +2.39% | ||
| 1 month | +5.03% | ||
| 3 months | +10.97% | ||
| 6 months | +32.43% | ||
| Current year | +2.39% |
| 1 week | 13,384 |  | 14,332 |
| 1 month | 13,278 | | 15,474.36 |
| Current year | 13,278 | | 14,332 |
| 1 year | 9,573.5 | | 15,474.36 |
| 3 years | 9,461 | | 15,474.36 |
| 5 years | 6,736 | | 15,474.36 |
| 10 years | 3,680 | | 15,474.36 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 65 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 65 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +0.93% | 8.29% | 62 M€ | |
| +3.90% | 5.39% | 1,412 M€ | |
| +1.34% | 5.17% | 26 M€ | |
| +2.64% | 4.89% | 787 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.68% | +5.50% | +30.47% | +23.34% | 296B | |
| +1.64% | +3.79% | +35.14% | +201.01% | 952B | |
| +2.61% | +2.65% | +47.63% | +20.53% | 492B | |
| -0.02% | -0.06% | +25.62% | +44.55% | 389B | |
| +0.50% | +5.22% | +29.29% | +18.53% | 363B | |
| -1.21% | +1.63% | +10.02% | -2.31% | 274B | |
| -0.18% | +4.92% | +25.39% | +35.33% | 273B | |
| -0.62% | +9.33% | -38.17% | -17.02% | 264B | |
| -0.17% | +1.50% | +24.14% | +20.16% | 176B | |
| +1.24% | +3.63% | +36.40% | +43.02% | 150B | |
| Average | +0.10% | +4.20% | +22.59% | +38.72% | 362.94B | |
| Weighted average by Cap. | +0.42% | +3.96% | +26.41% | +68.06% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 58.64B 50.21B 46.7B 43.53B 81.34B 5,285B 87.25B 538B 211B 2,528B 220B 215B 9,271B | 62.34B 53.38B 49.64B 46.28B 86.48B 5,619B 92.76B 572B 225B 2,688B 234B 229B 9,856B |
| Net income | 10.36B 8.88B 8.25B 7.69B 14.38B 934B 15.42B 95.08B 37.37B 447B 38.87B 38.07B 1,639B | 11.97B 10.25B 9.53B 8.89B 16.61B 1,079B 17.81B 110B 43.17B 516B 44.9B 43.98B 1,893B |
| Net Debt | 21.42B 18.34B 17.06B 15.9B 29.71B 1,930B 31.87B 196B 77.23B 924B 80.32B 78.68B 3,386B | 15.33B 13.13B 12.21B 11.38B 21.27B 1,382B 22.82B 141B 55.29B 661B 57.51B 56.33B 2,424B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 14,120.00 p | -0.68% | 2,194,240 |
| 09/01/26 | 14,216.00 p | +0.28% | 1,510,979 |
| 08/01/26 | 14,176.00 p | -0.34% | 2,489,394 |
| 07/01/26 | 14,224.00 p | +1.32% | 2,011,117 |
| 06/01/26 | 14,038.00 p | +4.89% | 2,054,017 |
Delayed Quote London S.E., January 12, 2026 at 08:35 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition